These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9143843)

  • 1. In situ hybridization of chromosome 6 on fine-needle aspirates from breast carcinomas: comparison of numerical abnormalities and ER/PgR status and staining pattern.
    Sauer T; Beraki K; Jebsen PW; Ormerod E; Naess O
    Diagn Cytopathol; 1997 May; 16(5):420-4. PubMed ID: 9143843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Numerical aberrations of chromosomes 1 and 7 by fluorescent in situ hybridization and DNA ploidy analysis in breast cancer.
    Kapranos N; Kounelis S; Karantasis H; Kouri E
    Breast J; 2005; 11(6):448-53. PubMed ID: 16297090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ploidy analysis by in situ hybridization of interphase cell nuclei in fine-needle aspirates from breast carcinomas: correlation with cytologic grading.
    Sauer T; Beraki K; Jebsen PW; Ormerod E; Naess O
    Diagn Cytopathol; 1997 Oct; 17(4):267-71. PubMed ID: 9316782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of numerical chromosome 17 abnormalities in fine-needle aspirates of breast cancer using a novel in situ hybridization signal amplification method.
    Schmitt FC; Soares R; Leitão D
    Diagn Cytopathol; 1998 Aug; 19(2):141-6. PubMed ID: 9702495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Numerical aberrations of chromosome 17 in interphase cell nuclei of breast carcinoma cells: lack of correlation with abnormal expression of p53, neu and nm23 protein.
    Sauer T; Beraki K; Jebsen PW; Ormerod E; Naess O
    APMIS; 1998 Oct; 106(10):921-7. PubMed ID: 9833692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Numerical abnormalities of chromosome 7 in interphase cell nuclei of breast carcinoma have no impact on immunohistochemically determined EGFR status.
    Sauer T; Beraki K; Jebsen PW; Naess O
    APMIS; 1999 Feb; 107(2):211-6. PubMed ID: 10225319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical analysis of receptors for estrogen and progesterone in fine-needle aspirates from human breast carcinomas.
    Skoog L; Humla S; Isaksson S; Tani E
    Diagn Cytopathol; 1990; 6(2):95-8. PubMed ID: 2186900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the oestrogen and progesterone receptor status in primary breast carcinomas as evaluated by immunohistochemistry and immunocytochemistry: a consecutive series of 267 patients.
    Domanski AM; Monsef N; Domanski HA; Grabau D; Fernö M
    Cytopathology; 2013 Feb; 24(1):21-5. PubMed ID: 22783929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: prognostic significance.
    Layfield LJ; Saria EA; Conlon DH; Kerns BJ
    J Surg Oncol; 1996 Mar; 61(3):177-84. PubMed ID: 8637203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of host and histopathological factors on the discrepancies in estrogen receptor, and progesterone receptor, and HER2 status between core needle biopsy and surgically excised tumors.
    Nakamura R; Yamamoto N; Shiina N; Miyaki T; Ikebe D; Itami M; Shida T; Miyazaki M
    Breast; 2016 Apr; 26():141-7. PubMed ID: 26732051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients.
    Elledge RM; Ciocca DR; Langone G; McGuire WL
    Cancer; 1993 Apr; 71(8):2499-506. PubMed ID: 8095853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor-negative progesterone receptor-positive breast cancer - "Nobody's land" or just an artifact?
    Kunc M; Biernat W; Senkus-Konefka E
    Cancer Treat Rev; 2018 Jun; 67():78-87. PubMed ID: 29772460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic analysis of breast carcinoma with chromosomal aneusomy detected by fluorescence in situ hybridization.
    Tsukamoto F; Miyoshi Y; Egawa C; Kasugai T; Takami S; Inazawa J; Noguchi S
    Cancer; 2001 Apr; 93(2):165-70. PubMed ID: 11309784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
    Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
    Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers.
    Nadji M; Gomez-Fernandez C; Ganjei-Azar P; Morales AR
    Am J Clin Pathol; 2005 Jan; 123(1):21-7. PubMed ID: 15762276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of numerical chromosomal abnormalities in malignant cells in fine needle aspirates by fluorescence in situ hybridization of interphase cell nuclei with chromosome-specific probes.
    Cajulis RS; Frias-Hidvegi D
    Acta Cytol; 1993; 37(3):391-6. PubMed ID: 8388611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status in the fine needle aspirates of metastatic breast carcinomas.
    Monaco SE; Wu Y; Teot LA; Cai G
    Diagn Cytopathol; 2013 Apr; 41(4):308-15. PubMed ID: 22045649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on estrogen and progesterone receptors in human breast cancer by sucrose gradient centrifugation (author's transl)].
    Iino Y
    Nihon Naibunpi Gakkai Zasshi; 1979 Aug; 55(8):971-93. PubMed ID: 488478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating loss of the wild-type p53 gene by in situ hybridization of fine-needle aspirates from breast carcinomas.
    Sauer T; Beraki K; Furu I; Ormerod E; Jebsen PW; Naess O
    Diagn Cytopathol; 1999 May; 20(5):266-70. PubMed ID: 10319226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
    Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M
    Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.